San Francisco—Spurred by such problems as the emergence of drug-resistant strains of HIV and adverse effects of current drug regimens, AIDS researchers are actively seeking new agents that use a novel strategy to foil the virus: blocking HIV's entry into target cells.
A number of groups are focusing their efforts on a promising group of compounds called "entry inhibitors," according to new findings presented here at the Seventh Annual Conference on Retroviruses and Opportunistic Infections.
Stephenson J. AIDS Researchers Explore New Drug Options. JAMA. 2000;283(9):1125. doi:10.1001/jama.283.9.1125